$VXRT
Vaxart Inc
PRICE
$3.34 ▲3.086%
Last Close
VOLUME
2,360,106
DAY RANGE
3.21 - 3.38
52 WEEK
2.49 - 10.33
Join Discuss about VXRT with like-minded investors
@DarkPoolAlgo #Dark Pool Charts
$VXRT if it follow this pattern I will be buying commons.
110 Replies 13 👍 14 🔥
@maletone #StockTraders.NET
messed up $VXRT and $SGLB but got back in after I got shook out
118 Replies 9 👍 15 🔥
@maletone #StockTraders.NET
damn muffed the $VXRT trade was hoping it would take out hod
129 Replies 11 👍 10 🔥
Key Metrics
Market Cap
422.20 M
Beta
1.88
Avg. Volume
3.17 M
Shares Outstanding
126.41 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Website: vaxart.com
HQ: ,
Related News